These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 24815764)

  • 61. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
    Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
    J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
    Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
    Lee WH; Loo CY; Rohanizadeh R
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nanoparticle assisted solvent selective transdermal combination therapy of curcumin and 5-flurouracil for efficient cancer treatment.
    Anirudhan TS; Nair AS; Bino SJ
    Carbohydr Polym; 2017 Oct; 173():131-142. PubMed ID: 28732851
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG containing curcumin: In vitro evaluation and pharmacokinetics in rats.
    Xu Y; Asghar S; Yang L; Chen Z; Li H; Shi W; Li Y; Shi Q; Ping Q; Xiao Y
    Int J Biol Macromol; 2017 Sep; 102():1083-1091. PubMed ID: 28472690
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
    Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
    Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glutathione-responsive self-delivery nanoparticles assembled by curcumin dimer for enhanced intracellular drug delivery.
    Zhang H; Zhang Y; Chen Y; Zhang Y; Wang Y; Zhang Y; Song L; Jiang B; Su G; Li Y; Hou Z
    Int J Pharm; 2018 Oct; 549(1-2):230-238. PubMed ID: 30071310
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
    Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer.
    Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MM
    Int J Biol Macromol; 2016 Dec; 93(Pt A):242-253. PubMed ID: 27565296
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer.
    Badran MM; Mady MM; Ghannam MM; Shakeel F
    Int J Biol Macromol; 2017 Feb; 95():643-649. PubMed ID: 27908720
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery.
    Salehiabar M; Nosrati H; Javani E; Aliakbarzadeh F; Kheiri Manjili H; Davaran S; Danafar H
    Int J Biol Macromol; 2018 Aug; 115():83-89. PubMed ID: 29653171
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
    Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
    Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
    [TBL] [Abstract][Full Text] [Related]  

  • 74. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.
    Chen H; Wu J; Sun M; Guo C; Yu A; Cao F; Zhao L; Tan Q; Zhai G
    J Liposome Res; 2012 Jun; 22(2):100-9. PubMed ID: 22007962
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
    Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
    Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lipophilic 5-fluorouracil prodrug encapsulated xylan-stearic acid conjugates nanoparticles for colon cancer therapy.
    Sauraj ; Kumar V; Kumar B; Deeba F; Bano S; Kulshreshtha A; Gopinath P; Negi YS
    Int J Biol Macromol; 2019 May; 128():204-213. PubMed ID: 30684574
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of the new pH-driven carrier from alginate/carboxymethyl starch bio-coated co-drugs@COF-OH for controlled and concomitant colon cancer treatment.
    Pooresmaeil M; Namazi H
    Int J Biol Macromol; 2023 Jun; 239():124322. PubMed ID: 37019202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles.
    Yan C; Gu J; Guo Y; Chen D
    Yakugaku Zasshi; 2010 Jun; 130(6):801-4. PubMed ID: 20519858
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer.
    Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A
    Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.